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Abstract: 
Alzheimer’s disease (AD) is a common neurodegenerative disease characterized by both extra- as well as intracellular 
deposition of amyloid beta peptides (Aβ). The accumulation of Aβ in mitochondria is associated with mitochondrial 
dysfunction and oxidative stress in AD. Recent evidences suggest the involvement of Aβ interaction with mitochondrial 
proteins such as cyclophilin-D (CypD) in oxidative stress, mitochondrial permeability transition (MPT) and Alzheimer’s 
associated neurodegeneration. The present study is an effort to elucidate the molecular interaction of Aβ with other proteins 
involved in MPT like adenine nucleotide translocase (ANT). Based on our prediction for sub-cellular localization using 
WolfPSORT and other experimental evidences, we suggest that Aβ molecules localize in mitochondrial inner membrane in 
close vicinity with ANT. Our simulation study for protein–protein interaction clearly suggests that the ANT-Aβ interaction is 
stronger than CypD-Aβ interaction. Further the lipophilic nature and evidences regarding the localization of Aβ in the 
mitochondrial inner-membrane also support the possibility of strong interaction between ANT and Aβ. Interaction between 
ANT and Aβ may affect normal physiological function of ANT i.e. transport of ATP and ADP. Since both the CypD-Aβ as 
well as ANT-Aβ interaction are energetically favorable and both CypD and ANT are associated with the regulation of MPT, 
the functional impact of both these interactions warrants more in-depth investigations for elucidating the mechanisms 
involved in Aβ-induced oxidative stress. 
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Background: 
Alzheimer’s disease (AD) is a common neurodegenerative 
disease that affects cognitive functions of the brain. The 
cardinal features of AD include the formation of 
extracellular protein deposits in the brain consisting 
predominantly of aggregates of amyloid beta (Aβ), 
intracellular neurofibrillary tangles, and disturbances in 
calcium homeostasis and degeneration of synapses and 
neurons  [1]. Despite these observable changes in the 
morphology and physiology of the brain the mechanism of 
neurodegeneration in AD is not clearly understood. An 
inflammatory process in the central nervous system is 
believed to play an important role in the pathways leading 
to neuronal cell death. In addition to inflammatory 
pathway (extracellular pathway of neurodegeneration), the 
Aβ mediated mitochondrial dysfunction and induction of 
intrinsic cell death has been recently realized as an 
important contributor in AD related neurodegeneration. 
Mitochondria play central role in the bioenergetics of cell 
and mitochondrial permeability transition pore (MPTP) has 
a central role in the regulation of both necrotic and 
apoptotic modes of neuronal cell death. Mitochondrial 
permeability transition (MPT) is described as an abrupt 
increase of inner membrane permeability to solutes with 
molecular mass of <1500 Da, which leads to dissipation of 
the mitochondrial membrane potential and influx of 
cytosolic solutes, causing expansion of matrix and finally 
the release of cytochrome-c leading to caspase activation 
and cell death [2]. Structurally the MPTP is thought to 
involve VDAC (voltage dependent anion channel) in the 
outer membrane, the ANT (adenine nucleotide translocase) 
in the inner membrane and CypD (Cyclophilin D) in the 
mitochondrial matrix. MPTP spans through both the inner 
and outer mitochondrial membranes. VDAC is a porin 
known by its role in metabolite transport across 
mitochondria and acts as entry for molecules from cytosol 
to mitochondria. Administration of specific anti-VDAC 
antibodies prior to Aβ-peptide uptake has been observed to 
prevent neurotoxicity, which suggests the role of MPTP in 
regulation of Aβ toxicity [3]. The other two major proteins 
of MPTP, CypD and ANT, have regulatory functions. 
CypD, which is a peptidyl prolyl cis-trans isomerase has 
been reported to regulate the MPTP. Oxidative and other 
stress promote CypD translocation to the inner membrane 
and this translocation acts as a key factor to trigger the 
opening of calcium-sensitive non-specific channels and 
subsequent change in mitochondrial calcium level. CypD 
deficiency has been recently reported to attenuate Aβ-
induced mitochondrial and neuronal perturbation, 
suggesting that its interaction with Aβ contributes to 
development of AD [5]. The other regulatory molecule 
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switch its function from ADP/ATP transporter to a pore-
forming channel during apoptosis. ANT is also proposed as 
a target for oxidative radicals that may finally lead to 
induction of pore opening [4]. Advancements in the 
molecular, cellular and animal model studies have revealed 
that Aβ enters mitochondria and induces the generation of 
free radicals. Aβ is a small peptide derived from regulated 
proteolysis of amyloid precursor protein (APP) in 
ER/Golgi compartments as well as in lysosomes and on the 
cell surfaces. Two complex proteases β- and γ- secretase 
are found involved in the generation of these toxic 
fragment  [6]. A β molecules at higher concentration can 
directly disrupt mitochondrial function and the interaction 
of Aβ with mitochondrial proteins (e.g. CypD) 
significantly enhances the accumulation and production of 
mitochondrial reactive oxygen species. Our present study 
offers an important advancement in the present 
understanding of MPTP opening and mitochondrial 
dysfunction in AD. In this study we have clearly 
demonstrated the predicted processing of APP as well as 
the interacting partners of Aβ in the cytoplasm, 
mitochondria and extracellular matrix. Our study strongly 
suggests that Aβ can interact with ANT (besides CypD) in 
the mitochondrial inner membrane, and this interaction is 
crucial for AD related pathophysiology.  
 
Methodology: 
Data set and Sequence retrieval:  
Amyloid beta keyword was used as input in the STITCH 
(protein-protein interaction resource database, 
http://stitch.embl.de). STITCH is a sister project of protein-
protein interaction server STRING and is a resource to 
explore known and predicted interactions over 1.5 million 
proteins from 373 species. ‘Homo sapiens’ was selected as 
the species of interest. The default setting for 20 outputs 
was changed to 50 interacting partners. We selected 
amyloid-beta A4 protein precursor. Out of the 50 
interacting proteins, 12 proteins (with >0.910 STITCH 
Score) related to the processing of APP with known role in 
AD development were selected for further study. We 
selected the interacting proteins based on their involvement 
in APP processing and proteolysis (Evin and Weidemann 
2002 [6] and http://www.uniprot.org). We also confirmed 
the interactions of these proteins with the database of 
predicted human protein-protein interactions PIPs 
(http://www.compbio.dundee.ac.uk/www-pips). In addition 
to these proteins, two proteins of MPTP, ANT and CypD 
were also selected and used for in silico interaction study. 
The related protein sequences were retrieved from the 
Entrez protein database (available at 
http://www.ncbi.nlm.nih.gov) using the protein name as 
keyword. Accession number for each sequence used for 
analysis is given (Table 2 in supplementary). 
 
Prediction of sub-cellular localization:  
All selected proteins were subjected to sub-cellular 
localization prediction using WolfPSORT server 
(http://wolfpsort.org) to know the relative abundance of 
these proteins in different sub-cellular compartments. The 
protein sequences retrieved from Entrez protein database 
were taken as input sequence. WolfPSORT predicts the 
sub-cellular localization sites of proteins based on both 
known sorting signal motifs and some corrective sequence 
features such as amino acid content with prediction 
accuracy of >80%. Further, the relative localization of 
different AD related proteins was correlated with protein-
protein interaction information available from STITCH.  
 
Protein-Protein interaction studies:  
The structural details of interactions between Aβ 
(1IYT_A), ANT (NP_001142) and CypD (NP_005029) 
were elucidated by molecular docking experiments. 3D 
models were constructed by automated protein structure 
homology-modeling Swissmodel server model 8.05 
(http://swissmodel.expasy.org/workspace). Protein-protein 
interaction simulation (docking) experiments were 
performed using RosettaDock server 
(http://rosettadock.graylab.jhu.edu). RosettaDock is a 
structure-prediction-based program based on SVM 
(support vector machine), which searches the rigid-body 
and side-chain conformational space of two interacting 
proteins to find a minimum free-energy complex structure. 
Further we also used Hex-5.1 software using solid surface 
docking simulations. In these docking calculations, each 
molecule is modeled using 3D expansions of real 
orthogonal spherical polar basis functions to encode both 
surface shape and electrostatic charge and potential 
distributions. All docking experiments were replicated 
1000 times and best Etotal for the interaction was taken as 
key parameter to evaluate the significance of interaction. 
Etotal was represented in terms of KJ/mol.  
 
Discussion: 
Prediction for presence and synthesis of Aβ in the 
mitochondria:  
First we performed sequence-based subcellular localization 
of some important proteins involved in APP processing, 
interaction and Aβ production. List of these proteins was 
obtained from STITCH database. WolfPSORT-based 
prediction for the sub-cellular localization indicated that 
neither amyloid precursors (APP) nor Aβ fragments are 
localized in the mitochondria (Table 1 in supplementary 
material). Interestingly, presence of secretase-β (beta-A 
and beta-B) involved in Aβ processing is predicted in 
mitochondria, indicating a possibility of Aβ processing 
inside the mitochondria. It was previously suggested that 
APP interacts with TOM and TIM proteins and gets a 
partial entry into the mitochondria via dual leader sequence 
[7]. Partially internalized APP may produce reduction of 
permeability of mitochondrial membranes due to 
engagement of TIM and TOM systems and it is suggested 
as a possible mechanism of mitochondrial dysfunction. It 
was also shown that amyloid portion of the APP resides 
outside of mitochondria, thus there is no internal 
generation of Aβ. Recently Hansson-Petersen et al. have 
shown that Aβ molecules are imported to mitochondria 
directly via TOM mechanism [8]. Presence of Aβ in the 
insoluble fraction suggests the integration of Aβ with lipid 
bilayer of inner membrane. It was suggested that its import 
is driven by hydrophobic interaction with receptors of 
TOM complex. As it has no classical signaling sequence it 
may interact with its hydrophobic domain but could not 
pass through inner membrane to mitochondrial matrix. 
Aβ1-42 has α-helical hydrophobic c-terminus sequence 
(residues 29-42) and is partially integrated in lipid layer. 
Integration of Aβ in the lipid bilayer forms ion channel like 
structures which are considered important in disrupting 
membrane potential. In vitro studies suggest that its 
integration into lipid layer is dependent on length and helix 
forming potential of hydrophobic sequence and is also 
regulated by metal ions, pH and constituents of lipid layer Bioinformation by Biomedical Informatics Publishing Group                              open access 
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[9]. Due to this the possibility of incorporation of Aβ1-42 
is greater than Aβ1-40. In many experiments the Aβ1-42 
has been reported more toxic than other amyloid fragments 
[10]. Further, we also wanted to study the localization of 
Aβ interacting proteins into the mitochondria, and we 
found the significantly higher score for mitochondrial 
localization of insulin protease, TGF-β, CypD and ANT 
(Table 1 in supplementary material). Since the CypD 
and ANT are known to regulate the mitochondrial 
membrane potential, we further explored the interaction of 
CypD, ANT with Aβ. 
 
 
Figure 1: Models of ANT-Aβ (A) and CypD-Aβ (C) complexes predicted by RosettaDock server along with  plots of scores 
(energy) versus distance from the starting structure of full set of 1000 structures created in docking run of Aβ with ANT (B) 
and CypD (D). In both the cases low energy structures are clustered around a single position as shown in dot plot. Most 
stable complex models of ANT- Aβ (E) and CypD-Aβ (F) predicted by Hex 5.1. Aβ is bound in hydrophobic region of ANT 
and low Etotal of ANT-Aβ complex showing its stability. Bioinformation by Biomedical Informatics Publishing Group                              open access 
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Interaction between Aβ, CypD and ANT:  
We hypothesized that amyloid beta may interact with 
ANT, an inner membrane transporter protein and may 
disrupt its function. We used interaction simulation with 
docking program RosettaDock server. The RosettaDock 
server performs a local docking search for a set of 
conformations for the optimal fit between the two proteins. 
Plot of 1000 simulated complexes shows a hallmark of a 
successful run in which low-energy structures clustered 
around a single position (Figure 1).  We also performed 
solid surface based docking simulation with software Hex 
5.1 and found that Aβ forms a very stable complex with 
ANT (Etotal= -577.65 kJ/mol) (Figure 1). Hydrophobic 
helix of Aβ chain is interacting with the hydrophobic 
transmembrane region of ANT. Also Aβ is abundant in the 
inner membrane, the localization site of ANT, indicating 
that possibility of its interaction with ANT is high. 
Interestingly, in our Hex interaction simulation, the 
binding of ANT (Etotal= -577.65 kJ/mol) with Aβ is 
stronger than that of CypD (Etotal= -454.21 kJ/mol) 
suggesting that binding of Aβ with ANT may even have 
pathogenic consequences. Our computer simulation based 
study shows that Aβ interacts with both ANT and CypD. 
Recently it was reported that stress induced by Aβ induces 
ROS generation and translocation of CypD to inner 
membrane, which results in mitochondrial swelling and 
cell death [5]. Genetic removal of CypD significantly 
protected the cells in this study. Authors suggested that Aβ 
interacts with CypD although its role in ROS generation 
was not clear. We sought to analyze the interaction with 
Aβ to understand role of Aβ in translocation of CypD and 
the opening of MPTP. Interestingly, our predictions of sub-
cellular localization as well as the results of Hansson-
Peterson et al. clearly rule out the presence of Aβ in the 
soluble or matrix fraction [8]. Therefore, this interaction is 
most likely possible in the inner membrane only.  
 
It is reported that under oxidative stress CypD is 
translocated to inner membrane and induces opening of 
MPTP [11], although the regulation of its translocation not 
clear. CypD and Aβ interaction is reportedly involved in 
the induction of oxidative stress and it is suggested that 
oxidative stress induced through CypD-Aβ may inhibit 
functioning of mitochondria and also induce cell death by 
other mechanisms such as Ca
++ independent signaling 
pathways, oxidative stress induced kinase system and 
activation of transcription factors. High abundance of Aβ 
in the inner membrane and its interaction with CypD may 
facilitate its anchoring in inner membrane, and in 
consequence its interaction with ANT may result in 
disturbance of mitochondrial membrane potential, 
mitochondrial swelling and cell death. Current evidences 
show that regulation of MPTP is very complex. Studies 
reveal that CypD binds tightly to VDAC-ANT and it seems 
more likely that the VDAC-ANT-CypD complex is a 
permanent feature of healthy cells and several mechanisms 
have been postulated to explain the MPTP opening [2, 11]. 
These mechanisms include changes in protein-protein 
interactions such as Bcl-2 or Bax binding, modulation of 
expression levels of pro- or anti-apoptotic components of 
MPTP, and modifications of the lipid microenvironment in 
mitochondrial membranes. Recent reports show that ANT 
has regulatory function rather than only the formation of 
structural transmembrane pore [12]. Our results show that 
Aβ tightly binds with ANT and may alter the interactions 
with pro- or anti-apoptotic factors. Also its localization and 
possible interaction with other proteins in the inner 
membrane may affect the lipid microenvironment. Aβ 
interaction with mitochondrial proteins namely ABAD 
(amyloid binding alcohol dehydrogenase) [13] and CypD 
[5] were found to produce reactive oxygen species (ROS) 
which can also alter the fluidity and permeability of 
membrane and may enhance mitochondrial dysfunction 
and synaptic dysfunction [14]. 
 
ANT transports ADP/ATP through an exchange-diffusion 
mechanism with a one-to-one stoichiometry and maintains 
the adenine nucleotide pool at a constant level in the 
matrix. During oxidative phosphorylation, external ADP 
enters into matrix and in exchange ATP is released into the 
inter-membrane space.  Nucleotides are transported in free 
form, thus the charge is not compensated and transport is 
driven by membrane potential at the cost of high energy 
consumption [15]. Interaction of Aβ with ANT may affect 
the physiological function of ANT and leads to dysfunction 
in energy metabolism prior to induction of cell death. Also 
ATP is directly involved in long term potentiation, a 
phenomenon involved in synaptic plasticity [16]. Our 
hypothesis is in line with the observation that 
mitochondrial dysfunction and in consequence synaptic 
dysfunction occurs much earlier than the neuronal loss [1, 
17].  
 
Conclusion: 
In this study we predicted the interaction between Aβ, 
CypD and ANT.  We found that Aβ may bind tightly with 
ANT which suggests that the interaction may alter 
regulation of MPTP and is involved in mitochondrial 
dysfunction. We also hypothesize that Aβ would interact 
with CypD and ANT in the inner mitochondrial membrane. 
Our prediction shows that the Etotal for ANT-Aβ interaction 
is significantly less than CypD-Aβ interaction, which 
shows that binding of Aβ with ANT is likely stronger than 
that with CypD, possibly affecting the normal 
physiological function of ANT. Hence we conclude that 
interaction of Aβ with ANT alone may induce 
mitochondrial dysfunction independent of MPTP. 
Dysregulation in ADP/ATP transport directly affects the 
physiological processes of cells and may further result in 
synaptic dysfunction. 
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Supplementary Material 
 
Table 1: Predicted sub-cellular localization for various amyloid protein processing enzymes as well as its interacting partners.  
   Cyto   Extr  Pero  Plas  ER  Mito  Cyto-
pero 
Lys  Gol  Nucl   Cyto-
Mito 
Cyto-
Nucl 
Amyloid beta1-42  17  10                3     
Amyloid  beta  1-40 17  12                  
beta-APP   13  8.5    7    5           
Secretase BETA A    7  13  5  3  2             
Secretase BETA B    8  12  4  4  2             
Secretase BETA C  2  8  13  3  4               
Secretase BETA D  2  8  13  3  3               
Presenilin 1        31                 
Apo E    25      2  3             
TGF beta    8  3      14    5      8.8   
AchE  precursor     18  8        3      
GAPDH 28          2             
Caspase 3 Precurssor  19  6      3          2     
Cathepsin beta    25            7         
Insulin protease  7.5          21          5.5   
Cyclophilin D  23          5            13.5 
ANT 12        3  15             
 
Table 2: List of APP interacting proteins  
Protein STITCH database  NCBI-ID  STITCH score 
PSEN1 (Presenilin-1) (467 aa)  AAH11729  0.999 
APOE (Apolipoprotein E precursor) (317 aa)  EAW57306  0.999 
BACE1 (Beta-secretase 1 precursor)  (531 aa)  NP_036236  0.998 
LRP1(Low-density lipoprotein receptor-related protein 1 precursor) (4544 aa)  NP_002323  0.998 
BACE2 (Beta secretase 2 precursor) (518 aa)  AAQ89286  0.992 
HADH2 (ABAD, 3-hydroxyacyl-CoA dehydrogenase type) (261 aa)  NP_001032900  0.988 
TGFB1 (Transforming growth factor beta 1 precursor)  (390 aa)  NP_000651  0.988 
PSEN2 (Presenilin-2)  (448 aa)  AAH06365  0.98 
ACHE (Acetylcholinesterase precursor) (641 aa)  AAC60618  0.973 
LRP1B (Low-density lipoprotein receptor-related protein 1B precursor) (4599 aa)  NP_061027  0.971 
ENSP00000229239 (Glyceraldehyde-3-phosphate dehydrogenase) (335 aa)  NP_002037  0.938 
NCSTN (Nicastrin precursor) (709 aa)  CAI15009  0.934 
CASP3 (Caspase-3 precursor) (277 aa)  CAC88866  0.929 
IDE (Insulin-degrading enzyme) (Insulin protease) (1019 aa)  CAI13670  0.927 
IL6 (Interleukin-6 precursor) (212 aa)  CAG29292  0.918 
MAPT (Microtubule-associated protein tau) (758 aa)  CAG26750  0.918 
HMOX2 (Heme oxygenase 2) (316 aa)  CAG46638  0.915 
CTSD (Cathepsin D precursor) (412 aa)  CAG33228  0.914 
 
 
 
 
 
 
 
 
 
 